Please use this identifier to cite or link to this item:
http://hdl.handle.net/2067/51565
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Marengo, Alessandro | it |
dc.contributor.author | Forciniti, Stefania | it |
dc.contributor.author | Dando, Ilaria | it |
dc.contributor.author | Dalla Pozza, Elisa | it |
dc.contributor.author | Stella, Barbara | it |
dc.contributor.author | Tsapis, Nicolas | it |
dc.contributor.author | Yagoubi, Najet | it |
dc.contributor.author | Fanelli, Giuseppina | it |
dc.contributor.author | Fattal, Elias | it |
dc.contributor.author | Heeschen, Christopher | it |
dc.contributor.author | Palmieri, Marta | it |
dc.contributor.author | Arpicco, Silvia | it |
dc.date.accessioned | 2024-07-23T07:55:13Z | - |
dc.date.available | 2024-07-23T07:55:13Z | - |
dc.date.issued | 2019 | it |
dc.identifier.issn | 0304-4165 | it |
dc.identifier.uri | http://hdl.handle.net/2067/51565 | - |
dc.description.abstract | Pancreatic cancer stem cells (CSCs) are responsible for resistance to standard therapy, metastatic potential, and disease relapse following treatments. The current therapy for pancreatic ductal adenocarcinoma (PDAC) preferentially targets the more differentiated cancer cell population, leaving CSCs as a cell source for tumor mass formation and recurrence. For this reason, there is an urgent need to improve current therapies and develop novel CSC-targeted therapeutic approaches. | it |
dc.language.iso | eng | it |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes | it |
dc.type | article | * |
dc.identifier.doi | 10.1016/j.bbagen.2018.09.018 | it |
dc.identifier.pmid | 30267751 | it |
dc.identifier.scopus | s2.0-85047862536& | it |
dc.identifier.url | www.elsevier.com/locate/bbagen | it |
dc.relation.journal | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | it |
dc.relation.firstpage | 61 | it |
dc.relation.lastpage | 72 | it |
dc.relation.volume | 1863 | it |
dc.relation.issue | 1 | it |
dc.subject.keywords | CD44; Diethyldithiocarbamate/copper complex; Hyaluronic acid; Liposomes; Pancreatic cancer stem cells; PDAC patient-derived cells; Biophysics; Biochemistry; Molecular Biology | it |
dc.description.numberofauthors | 12 | it |
dc.type.referee | REF_1 | it |
dc.type.miur | 262 | * |
item.fulltext | With Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.grantfulltext | restricted | - |
item.openairetype | article | - |
item.cerifentitytype | Publications | - |
crisitem.journal.journalissn | 0304-4165 | - |
crisitem.journal.ance | E022079 | - |
Appears in Collections: | A1. Articolo in rivista |
Files in This Item:
File | Description | Size | Format | Existing users please |
---|---|---|---|---|
1-s2.0-S0304416518303064-main (2).pdf | 2.76 MB | Adobe PDF | Request a copy |
SCOPUSTM
Citations
53
Last Week
0
0
Last month
checked on Sep 16, 2024
Page view(s)
55
checked on Sep 18, 2024
Google ScholarTM
Check
Altmetric
This item is licensed under a Creative Commons License